Skip to content

Avient stock

AVNTNYSE

Avient Corporation, Basic MaterialsISIN US05368V1061

$44.92▼ $1.31 (−2.8%)Closing price of 12 Nov 2026

61Score 61 out of 100, Neutral

Turn on early warning

Price and trend

84 / 100

Price history

+52% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 15% above it.

Trend change

Since February 2026 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Normal: the price is neither overheated nor sold off (RSI 64).

Distance to the high

The price is 6.1% below its 52-week high. Largest decline in 20 years: 85% (July 2007 to March 2009).

Chart figures for advanced users
SMA 50$41.74
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$38.89
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)64
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$27.48
The lowest closing price of the last twelve months.
Resistance$47.86
The highest closing price of the last twelve months.
Market cap
$4.24B
Div. yield
2.38%
12 months
23.7
on reported earnings of the last twelve months
13.0
on earnings for the next twelve months ($3.56 per share)
Fair value
$50.43

Snapshot

Computed from the data by fixed rules, no AI

  • Avient Corporation belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $4.12B, is number 71 of 108 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $3.26B (up 0.6% year on year) and earnings of $81.9M (down 51.7%).
  • For fiscal 2026, analysts expect on average revenue of $3.45B (up 5.7%) and adjusted earnings per share of $3.24 (up 15%).
Show more
  • MEQIRI Score 61 out of 100 (Neutral): rank 188 of 467 in Basic Materials, median 58.
  • The P/E is 23.1 (Chemicals (Specialty) median 24.4, own median of recent years 22.1).
  • Our model puts fair value at $50.43, with the price 8% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Reliable dividendNo dividend cut for 15 years.

Weaknesses

None of our weakness checks flags anything. Crash risk is measured separately.

61/ 100
MEQIRI Score
Neutral

Its standout strengths are momentum and technical analysis, while profitability and capital allocation hold the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

The fundamentals are in the middle range.

Profit consistency90% of years
Cash conversion (free cash flow to earnings, 12 months)56%
ROIC (12 months)6.4%
Positive free cash flow100% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among smaller stocks.

From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • cyclical sector (energy or materials), as a group, crashed more often in the backtest

What lowers it

  • price near its 52-week high
  • stable momentum

Valuation

Valuation signal

Fairly valued
Price
$46.23
Fair value
$50.43
Gap to fair value
−8%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $38.79 and expensive above $72.05 (uncertainty medium, based on the price swings of the past year).

The two parts of the fair value come to $53.40 (cash-flow model) and $47.46 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is slightly below both parts; given how much the stock swings, that still counts as fair.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $45.84, at 7.8% it would be $57.34.

Valuation metrics

2.93
11.2
Fair value (model)
$50.43
Earnings part $47.46 (earnings per share $1.95 × 24.4)

Half from the cash-flow model, half from earnings times the industry P/E (24.4).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 30 Sep 2026, revenue rose 5.2% on the twelve months before. Up to 2020 the bars include businesses that were later spun off or sold. On a comparable basis, as restated in the SEC annual reports, revenue grew 8% a year.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 32%, operating 6%, net 3%.

Debt & balance sheet

latest quarter
0.74
3.7x
1.71
Cash & equivalents
$445.7M

Moderate debt, and interest is adequately covered.

Earnings

Next earnings
11 Feb 2027in 91 days
Last reported
4 Nov 2026EPS reported $0.86 (expected $0.80)above expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20263 analysts
Earnings per share
$3.24+1.3%
Revenue
$3.45B+0.8%
Fiscal 20276 analysts
Earnings per share
$3.61+1.8%
Revenue
$3.58B+1.2%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook raised

Share price after the results: +20.5%

2026 guidance raised: adjusted EBITDA of $575 to $603 million, adjusted EPS of $3.10 to $3.25 and free cash flow of $210 to $230 million; capex lowered to $120 to $130 million.

Supporting passage from the call, verbatim
“We now expect adjusted EBITDA to be in the range of $575 million to $603 million, adjusted EPS to be in the range of $3.10 to $3.25 per share and free cash flow to be in the range of $210 million to $230 million.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 6 Aug 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases or sales in the last 6 months.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Avient

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

467 rated companies in Basic Materials

Rank 188 of 467
188/ 467
This company
61
Sector median
58

Categories against the sector median

ProfitabilityMedian of 467 companies44 (median 49)5 below the median
GrowthMedian of 467 companies44 (median 54)10 below the median
FundamentalsMedian of 467 companies66 (median 65)1 above the median
ValuationMedian of 426 companies with a value58 (median 69)11 below the median
StabilityMedian of 467 companies63 (median 67)4 below the median
Capital allocationMedian of 467 companies44 (median 52)8 below the median
Technical analysisMedian of 467 companies84 (median 54)30 above the median
MomentumMedian of 467 companies96 (median 51)45 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Chemicals (Specialty)

The next larger and next smaller companies by market value

All 108 Chemicals (Specialty) stocks

ETFs that hold Avient

Held by 16 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
WisdomTree US High Dividend UCITS ETF AccWTD90.28%0.29%€182.46M
WisdomTree US Equity Income UCITS ETF EUR Hedged AccWTDY0.26%0.35%€204.34M
L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ0.15%0.30%€185.82M
Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Apr 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy